Glycogen storage disease type IX: High variability in clinical phenotype

Area of Science:

• Biochemistry
• Genetics
• Pediatric Medicine

Background:

• Glycogen storage disease type IX (GSD type IX) stems from deficient hepatic phosphorylase kinase activity.
• The condition arises from mutations in PHKA2, PHKB, and PHKG2 genes, encoding liver phosphorylase kinase subunits.
• Diagnosis is challenging due to varied clinical presentations, tissue specificity, severity, and inheritance patterns (X-linked or autosomal recessive).

Purpose of the Study:

• To investigate the genetic basis of GSD type IX in patients with suspected disease.
• To characterize causative mutations in PHKA2, PHKG2, and PHKB genes.
• To correlate genotype with phenotype and inheritance patterns for improved diagnosis and counseling.

Main Methods:

• Studied 15 patients from 12 families with suspected GSD type IX.
• Performed molecular analysis to identify mutations in PHKA2, PHKG2, and PHKB genes.
• Correlated identified mutations with clinical symptoms, biochemical findings, and inheritance patterns.

Main Results:

• Causative mutations were identified in PHKA2 (10 patients), PHKG2 (2 patients), and PHKB (3 patients).
• Seven novel mutations in PHKA2, two in PHKG2, and two in PHKB were discovered.
• PHKG2 mutations were associated with severe phenotypes, PHKB with mild, and PHKA2 with a broad spectrum.

Conclusions:

• Molecular analysis provides accurate diagnosis for GSD type IX, especially when enzymology is inconclusive.
• Genetic characterization identifies inheritance patterns, facilitating genetic counseling and family studies.
• Genotype-phenotype correlations enhance understanding of GSD type IX variability and guide clinical management.